Accuray eyes big AF (atrial fibrillation) market with CyberHeart deal
This article was originally published in Clinica
Executive Summary
Promising to pave its entry into the large atrial fibrillation (AF) therapy market, Accuray has agreed to let CyberHeart assess whether its CyberKnife robotic radiosurgery system can be used to develop a novel and noninvasive method for performing cardiac ablations.